Accuri C6 Flow Cytometer System
A more recent version of this article appeared on October 1, 2008

Published online before print July 14, 2008
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0108064v1
84/4/1120    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundararaj, K. P.
Right arrow Articles by Huang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundararaj, K. P.
Right arrow Articles by Huang, Y.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0108064

Received for publication January 25, 2008.
Revised June 13, 2008.
Accepted for publication June 18, 2008.

Article

Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation-mediated ERK activation

Kamala P. Sundararaj *, Devadoss J. Samuvel *, Yanchun Li {dagger}, Alena Nareika *, Elizabeth H. Slate {ddagger}, John J. Sanders {sect}, Maria F. Lopes-Virella *{dagger}, and Yan Huang *{dagger}@

{dagger}Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, USA; and *Division of Endocrinology, Diabetes and Medical Genetics, Department of Medicine, {ddagger}Department of Biostatistics, Bioinformatics & Epidemiology, and {sect}Division of Periodontics, Department of Stomatology, Medical University of South Carolina, Charleston, South Carolina, USA

@ To whom correspondence should be addressed. E-mail: huangyan{at}musc.edu.


arrow
Abstract

Matrix metalloproteinase (MMP) plays a crucial role in periodontal disease and is up-regulated by oral Gram-negative, pathogen-derived LPS. In this study, we reported that simvastatin, a 3-hydroxyl-3-methylglutaryl-CoA reductase inhibitor, effectively inhibited LPS-stimulated MMP-1 as well as MMP-8 and MMP-9 expression by U937 mononuclear cells. Our studies showed that the geranylgeranyl transferase inhibitor inhibited LPS-stimulated MMP-1 expression, and addition of isoprenoid intermediate geranylgeranyl pyrophosphate (GGPP) reduced the inhibitory effect of simvastatin on LPS-stimulated MMP-1 expression. We also demonstrated that simvastatin inhibited the activation of Ras and Rac, and the inhibition was abolished by addition of GGPP. The above results indicate that protein isoprenylation is involved in the regulation of MMP-1 expression by LPS and simvastatin. Moreover, we showed that simvastatin inhibited LPS-stimulated nuclear AP-1, but not NF-{kappa}B activity, and the inhibition was reversed by addition of GGPP. Simvastatin also inhibited LPS-stimulated ERK but not p38 MAPK and JNK. Finally, we showed that the inhibition of LPS-stimulated ERK activation by simvastatin was reversed by GGPP. Taken together, this study showed that simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by targeting protein isoprenylation-mediated ERK activation.

Key Words: matrix metalloproteinases • statin • lipopolysaccharide • mitogen-activated protein kinase • gene expression